A supplement specification defines the approved requirements a material or product must meet. A certificate of analysis (COA) reports results for a particular lot against stated criteria.
Before batch release, compare the two, confirm they refer to the right material and version, and review the rest of the release record. A passing COA alone is not the release decision.
For US dietary supplements, the applicable responsibilities depend on the operation and written quality system. This guide helps brand teams ask better questions; it does not replace the manufacturer’s quality-control review or regulatory advice.
How Does a Supplement Specification Differ From a Certificate of Analysis?
A specification is the benchmark. Depending on its scope, it can identify the product, applicable tests, acceptance criteria, units, methods, and approved version. Component, in-process, and finished-product specifications serve different purposes.
A COA is lot-specific evidence. It generally identifies the material and lot, reports applicable results and methods, and shows the criteria used for comparison. A component COA is not the same document as a finished-product COA, and neither proves that every other release requirement was met.
The FDA’s dietary supplement CGMP guide explains the need for specifications and for quality-control review of batch records and release decisions.

Compare the Documents Before You Discuss Release
Start with the approved specification in effect for the batch and the corresponding lot-specific results. Then compare each line by test, method, units, acceptance criterion, and result. The table is a conversation aid, not a universal testing panel.

| Review point | Specification | COA or release record |
| Identity | Approved product and code | Matching product and lot |
| Acceptance criteria | Approved limits and units | Result against correct limits |
| Methods | Approved or referenced methods | Method used and reported result |
| Disposition | Requirements for acceptance | Quality decision and supporting record |
If a COA says only ‘conforms,’ ask for the supporting evidence and method. When relying on a supplier COA under 21 CFR 111.75(a)(2), the certificate must describe the methods and test or examination limits and report actual results; a bare ‘conforms’ statement alone does not meet that condition. A missing line does not automatically mean the batch failed, but it does require an explanation before the quality team makes its decision.
Confirm the Product, Lot, and Specification Version
Match the product name, formulation or item code, lot identifier, and document issuer to the batch under review. Check whether the report covers a raw ingredient, bulk blend, or finished packaged product. A valid result for the wrong lot is not evidence for this batch.
Check the approved specification revision and effective date against the batch record. If the COA uses an older limit or different product code, pause and ask quality personnel to reconcile the discrepancy through the documented change-control process.
Read Results Against the Right Criteria
Compare like with like. For example, a result expressed per capsule cannot be compared directly with a limit per serving unless the serving size and conversion are clear. A calculated example can explain the arithmetic, but the approved specification and qualified reviewer control the actual decision.
Review identity, strength, composition, purity, and relevant contaminant limits as applicable to the product and its control strategy. Ask which tests were performed on the finished batch, which relied on component or in-process controls, and how the selected controls support the finished-product specification.
The FDA guide describes testing or examination of selected finished-product specifications on every finished batch or a subset under a sound statistical sampling plan, with additional requirements for any permitted exemption. It does not require assuming that every possible test appears on every COA.
Know What a Supplier COA Can and Cannot Replace
For dietary ingredients, Part 111 generally requires at least one appropriate identity test or examination on each received component, subject to a permitted exemption. For certain other component specifications, 21 CFR 111.75(a)(2) permits reliance on a supplier COA only when its conditions are met, including supplier qualification and periodic confirmation. The certificate must describe the methods and test or examination limits and provide actual results; a bare ‘conforms’ statement is insufficient.
Do not treat a supplier’s document as an automatic substitute for identity testing or for the manufacturer’s quality system. Ask the responsible quality team how it qualified the supplier, verified the certificate, and documented the basis for its controls.
Review the Batch Record and Any Exceptions
Before release, confirm that the quality team has reviewed the batch production record, required testing and examinations, packaging and label checks, and any deviations or investigations. Ask who owns each review and how an unresolved discrepancy is held and resolved.
For an out-of-specification or unexplained result, request the documented investigation and disposition rather than a revised certificate alone. Retesting, reprocessing, rejection, or release must follow applicable requirements and the firm’s procedures; a brand should not instruct a lab to discard an unfavorable result.

A 2025 FDA-affiliated survey of 110 melatonin products marketed for children found melatonin in 108 and measured content ranging from 0% to 667% of the label declaration. This targeted sample is not representative of all supplements or evidence about CPack batches. It illustrates why the identity of the tested product, method, and actual result matter.


Agree on the Release Package Early
Before production, agree on the specification version, tests and methods, sampling approach, units, reporting format, deviations, and who receives which documents. Clarify whether a COA covers the finished product, individual ingredients, or both. A quality agreement can assign communication responsibilities, but it does not erase applicable regulatory duties.
If you are planning a capsule product, CPack’s capsule manufacturing page describes its service. Share the formula, target amounts, format, packaging, intended market, and requested documentation when discussing the project. For related context, see CPack’s guide to variation between capsules. Request a quote to discuss your product and documentation needs.
Frequently Asked Questions
No. A specification sets criteria; a COA reports results or conformance for a particular lot against stated criteria.
No. The responsible quality personnel must review applicable records and make the release or rejection decision under the quality system.
Not automatically. The rule generally requires an appropriate identity test or examination for each dietary ingredient component, subject to an applicable exemption.
The testing strategy and report scope vary. Ask quality personnel how the relevant specification is verified and what supporting records exist.
Pause the comparison and ask the quality team for the documented conversion, serving basis, and assessment against the approved criterion.